221 related articles for article (PubMed ID: 36333165)
1. TNFRSF13B in B cell responses to organ transplantation.
Cascalho M; Platt JL
Hum Immunol; 2023 Jan; 84(1):27-33. PubMed ID: 36333165
[TBL] [Abstract][Full Text] [Related]
2. TNFRSF13B genotypes control immune-mediated pathology by regulating the functions of innate B cells.
de Mattos Barbosa MG; Lefferts AR; Huynh D; Liu H; Zhang Y; Fu B; Barnes J; Samaniego M; Bram RJ; Geha RS; Shikanov A; Prak ETL; Farkash EA; Platt JL; Cascalho M
JCI Insight; 2021 Sep; 6(17):. PubMed ID: 34283811
[TBL] [Abstract][Full Text] [Related]
3. TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development.
Romberg N; Virdee M; Chamberlain N; Oe T; Schickel JN; Perkins T; Cantaert T; Rachid R; Rosengren S; Palazzo R; Geha R; Cunningham-Rundles C; Meffre E
J Allergy Clin Immunol; 2015 Nov; 136(5):1315-25. PubMed ID: 26100089
[TBL] [Abstract][Full Text] [Related]
4.
Cascalho M; Platt JL
Front Immunol; 2021; 12():634544. PubMed ID: 33679786
[TBL] [Abstract][Full Text] [Related]
5. Deficiency in TNFRSF13B (TACI) expands T-follicular helper and germinal center B cells via increased ICOS-ligand expression but impairs plasma cell survival.
Ou X; Xu S; Lam KP
Proc Natl Acad Sci U S A; 2012 Sep; 109(38):15401-6. PubMed ID: 22949644
[TBL] [Abstract][Full Text] [Related]
6. TNFRSF13B polymorphisms counter microbial adaptation to enteric IgA.
Platt JL; de Mattos Barbosa MG; Huynh D; Lefferts AR; Katta J; Kharas C; Freddolino P; Bassis CM; Wobus C; Geha R; Bram R; Nunez G; Kamada N; Cascalho M
JCI Insight; 2021 Jul; 6(14):. PubMed ID: 34111031
[TBL] [Abstract][Full Text] [Related]
7. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes.
Salzer U; Bacchelli C; Buckridge S; Pan-Hammarström Q; Jennings S; Lougaris V; Bergbreiter A; Hagena T; Birmelin J; Plebani A; Webster AD; Peter HH; Suez D; Chapel H; McLean-Tooke A; Spickett GP; Anover-Sombke S; Ochs HD; Urschel S; Belohradsky BH; Ugrinovic S; Kumararatne DS; Lawrence TC; Holm AM; Franco JL; Schulze I; Schneider P; Gertz EM; Schäffer AA; Hammarström L; Thrasher AJ; Gaspar HB; Grimbacher B
Blood; 2009 Feb; 113(9):1967-76. PubMed ID: 18981294
[TBL] [Abstract][Full Text] [Related]
8. Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency.
Mohammadi J; Liu C; Aghamohammadi A; Bergbreiter A; Du L; Lu J; Rezaei N; Amirzargar AA; Moin M; Salzer U; Pan-Hammarström Q; Hammarström L
J Clin Immunol; 2009 Nov; 29(6):777-85. PubMed ID: 19629655
[TBL] [Abstract][Full Text] [Related]
9. Transmembrane activator and CAML interactor (TACI) haploinsufficiency results in B-cell dysfunction in patients with Smith-Magenis syndrome.
Chinen J; Martinez-Gallo M; Gu W; Cols M; Cerutti A; Radigan L; Zhang L; Potocki L; Withers M; Lupski JR; Cunningham-Rundles C
J Allergy Clin Immunol; 2011 Jun; 127(6):1579-86. PubMed ID: 21514638
[TBL] [Abstract][Full Text] [Related]
10. Clinical Associations of Biallelic and Monoallelic TNFRSF13B Variants in Italian Primary Antibody Deficiency Syndromes.
Pulvirenti F; Zuntini R; Milito C; Specchia F; Spadaro G; Danieli MG; Pession A; Quinti I; Ferrari S
J Immunol Res; 2016; 2016():8390356. PubMed ID: 27123465
[TBL] [Abstract][Full Text] [Related]
11. Methylation of TNFRSF13B and TNFRSF13C in duodenal mucosa in canine inflammatory bowel disease and its association with decreased mucosal IgA expression.
Maeda S; Ohno K; Fujiwara-Igarashi A; Tomiyasu H; Fujino Y; Tsujimoto H
Vet Immunol Immunopathol; 2014 Jul; 160(1-2):97-106. PubMed ID: 24814046
[TBL] [Abstract][Full Text] [Related]
12.
Tsiouma GK; Skoulakis CE; Lachanas VA; Sevdali EG; Tsinti GN; Florou ZA; Petinaki EA; Speletas MG
Am J Rhinol Allergy; 2023 Jan; 37(1):74-77. PubMed ID: 36305039
[TBL] [Abstract][Full Text] [Related]
13. TACI deficiency - a complex system out of balance.
Salzer U; Grimbacher B
Curr Opin Immunol; 2021 Aug; 71():81-88. PubMed ID: 34247095
[TBL] [Abstract][Full Text] [Related]
14. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
Lee JJ; Ozcan E; Rauter I; Geha RS
Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
[TBL] [Abstract][Full Text] [Related]
15. Heterozygous alterations of TNFRSF13B/TACI in tonsillar hypertrophy and sarcoidosis.
Speletas M; Salzer U; Florou Z; Petinaki E; Daniil Z; Bardaka F; Gourgoulianis KI; Skoulakis C; Germenis AE
Clin Dev Immunol; 2013; 2013():532437. PubMed ID: 23956760
[TBL] [Abstract][Full Text] [Related]
16. Three different classifications, B lymphocyte subpopulations, TNFRSF13B (TACI), TNFRSF13C (BAFF-R), TNFSF13 (APRIL) gene mutations, CTLA-4 and ICOS gene polymorphisms in Turkish patients with common variable immunodeficiency.
Kutukculer N; Gulez N; Karaca NE; Aksu G; Berdeli A
J Clin Immunol; 2012 Dec; 32(6):1165-79. PubMed ID: 22699762
[TBL] [Abstract][Full Text] [Related]
17. Sequence analysis of TNFRSF13b, encoding TACI, in patients with systemic lupus erythematosus.
Salzer U; Birmelin J; Bacchelli C; Witte T; Buchegger-Podbielski U; Buckridge S; Rzepka R; Gaspar HB; Thrasher AJ; Schmidt RE; Melchers I; Grimbacher B
J Clin Immunol; 2007 Jul; 27(4):372-7. PubMed ID: 17464555
[TBL] [Abstract][Full Text] [Related]
18. The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice.
Bacchelli C; Buckland KF; Buckridge S; Salzer U; Schneider P; Thrasher AJ; Gaspar HB
J Allergy Clin Immunol; 2011 May; 127(5):1253-9.e13. PubMed ID: 21458042
[TBL] [Abstract][Full Text] [Related]
19. An evolutionary approach to the medical implications of the tumor necrosis factor receptor superfamily member 13B (TNFRSF13B) gene.
Sazzini M; Zuntini R; Farjadian S; Quinti I; Ricci G; Romeo G; Ferrari S; Calafell F; Luiselli D
Genes Immun; 2009 Sep; 10(6):566-78. PubMed ID: 19494827
[TBL] [Abstract][Full Text] [Related]
20. Accommodation in allogeneic and xenogeneic organ transplantation: Prevalence, impact, and implications for monitoring and for therapeutics.
Platt JL; Cascalho M
Hum Immunol; 2023 Jan; 84(1):5-17. PubMed ID: 36244871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
